A Phase 3, Open-Label, Randomized Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Details
Age
Adult
Locations
CTRC Inpatient
University of Colorado Hospital
Principal Investigator
MANALI KAMDAR
Study ID
Protocol Number: 23-1756
More information available at ClinicalTrials.gov: NCT06073821
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers